New pill hopes to ease Parkinson's symptoms
NCT ID NCT07142044
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 27 times
Summary
This study tests an experimental oral drug called EC5026 in 18 adults with Parkinson's disease. The main goal is to see if the drug is safe and how it works in the body, but researchers will also check if it helps improve symptoms. Participants take the drug or a placebo daily for 28 days and undergo regular checkups, blood tests, and spinal fluid tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California Davis
RECRUITINGSacramento, California, 95817, United States
Conditions
Explore the condition pages connected to this study.